A systematic review of human clinical trials carried out between 1980 and 2019 revealed that curcumin supplementation increased IL-10 levels and decreased MCP-1, TNF-α, IL-6, and CRP levels, reflecting its anti-inflammatory properties in chronic inflammation [350]. Here, CCL2 is linked to inflammatory response.